PRIMECAP MANAGEMENT CO 13D and 13G filings for Epizyme, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-08 4:01 pm Sale |
2022-08-31 | 13G | Epizyme, Inc. EPZM |
PRIMECAP MANAGEMENT CO | 0 0.000% |
-15,598,934 (Position Closed) |
Filing |
| 2022-08-09 4:01 pm Purchase |
2022-07-31 | 13G | Epizyme, Inc. EPZM |
PRIMECAP MANAGEMENT CO | 15,598,934 9.270% |
251,157 (+1.64%) |
Filing |
| 2022-02-10 11:56 am Sale |
2022-01-31 | 13G | Epizyme, Inc. EPZM |
PRIMECAP MANAGEMENT CO | 15,347,777 9.430% |
-18,700 (-0.12%) |
Filing |
| 2022-02-08 2:03 pm Purchase |
2021-12-31 | 13G | Epizyme, Inc. EPZM |
PRIMECAP MANAGEMENT CO | 15,366,477 14.790% |
157,950 (+1.04%) |
Filing |
| 2021-02-12 12:02 pm Purchase |
2009-02-28 | 13G | Epizyme, Inc. EPZM |
PRIMECAP MANAGEMENT CO | 15,208,527 14.970% |
140,100 (+0.93%) |
Filing |
| 2020-10-08 7:02 pm Purchase |
2009-02-28 | 13G | Epizyme, Inc. EPZM |
PRIMECAP MANAGEMENT CO | 15,068,427 14.850% |
1,409,323 (+10.32%) |
Filing |